Microbial Biotechnology Business

Expanding our Business by Providing ‘One-stop’ Customer Services from Process Development – Scaling-Up – EPC – Production Support

Chiyoda’s experience includes the engineering, procurement and construction (EPC) of pharmaceutical plants with large scale-up potential, for manufacturing bio-pharmaceuticals such as vaccines and antibodies, and our aim is to expand our business into the following areas:

Chiyoda has implemented the following initiatives:

• Developing technology^* to establish a strategy for faster scale-up, including establishing/selecting large-sized fermenters and scale-up/scale-down systems from laboratory-scale bioreactors through simulation;
• Testing digital technologies for applicability based on data obtained by simulation-analysis and culturing.

• The following actions have been implemented under a collaborative study with the Bio Manufacturing Laboratory of the Osaka Institute of Technology.

The Chiyoda laboratoy has been established within the Shonan Health Innovation Park (Shonan iPark).
We are conducting data acquisition on cultured model strains using a laboratory-scale (2L) bioreactor and performing of the physical properties of culture media using a viscometer.